- Home
- MSB vs LFCR Comparison
MSB vs LFCR Comparison
Compare MSB & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSB
- LFCR
- Stock Information
- Founded
- MSB 1961
- LFCR 1986
- Country
- MSB United States
- LFCR United States
- Employees
- MSB N/A
- LFCR N/A
- Industry
- MSB Metal Mining
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- MSB Basic Materials
- LFCR Health Care
- Exchange
- MSB Nasdaq
- LFCR Nasdaq
- Market Cap
- MSB 320.9M
- LFCR 308.8M
- IPO Year
- MSB N/A
- LFCR N/A
- Fundamental
- Price
- MSB $30.92
- LFCR $7.61
- Analyst Decision
- MSB
- LFCR Buy
- Analyst Count
- MSB 0
- LFCR 4
- Target Price
- MSB N/A
- LFCR $8.00
- AVG Volume (30 Days)
- MSB 48.2K
- LFCR 108.3K
- Earning Date
- MSB 01-01-0001
- LFCR 08-07-2025
- Dividend Yield
- MSB 22.43%
- LFCR N/A
- EPS Growth
- MSB 335.65
- LFCR N/A
- EPS
- MSB 7.12
- LFCR N/A
- Revenue
- MSB $25,894,592.00
- LFCR $128,867,000.00
- Revenue This Year
- MSB N/A
- LFCR $4.78
- Revenue Next Year
- MSB N/A
- LFCR $12.02
- P/E Ratio
- MSB $4.34
- LFCR N/A
- Revenue Growth
- MSB N/A
- LFCR 0.47
- 52 Week Low
- MSB $16.55
- LFCR $3.68
- 52 Week High
- MSB $37.00
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- MSB 54.91
- LFCR 53.94
- Support Level
- MSB $30.68
- LFCR $7.33
- Resistance Level
- MSB $33.25
- LFCR $7.73
- Average True Range (ATR)
- MSB 1.06
- LFCR 0.30
- MACD
- MSB -0.24
- LFCR 0.03
- Stochastic Oscillator
- MSB 27.41
- LFCR 65.33
About MSB Mesabi Trust
Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of its assets. The company's principally wholly-owned segment is the iron ore mining segment, which generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.